Metoclopramide - Generic Drug Details
✉ Email this page to a colleague
Recent Clinical Trials for metoclopramide
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Montefiore Medical Center | PHASE4 |
| Mercy Bon Secours Saint Vincent Medical Center | PHASE3 |
| Umraniye Education and Research Hospital | NA |
US Patents and Regulatory Information for metoclopramide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meda Pharms | REGLAN ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021793-001 | Jun 10, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | INJECTABLE;INJECTION | 071291-001 | Mar 3, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mutual Pharm | METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | TABLET;ORAL | 070660-001 | Feb 10, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novel Labs Inc | METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202191-002 | Aug 15, 2014 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |


